Latest news
Viridian Therapeutics (VRDN) Stock Rises Despite Deepening Losses And Cash Burn - simplywall.stsimplywall.st · Sat, 08 Aug 2026 06:03:54 GMTS&W Bodyguard 2.0 + Viridian Green Dot: Pocket Size, Major Upgrade? - YouTubeYouTube · Fri, 07 Aug 2026 20:55:45 GMTViridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 16:08:56 GMTState Street Corporation (NASDAQ: VRDN) discloses 5.5% Viridian Therapeutics ownership - stocktitan.netstocktitan.net · Fri, 07 Aug 2026 15:13:34 GMTRBC Adjusts Viridian Therapeutics PT to $36 From $35, Maintains Outperform Speculative Risk Rating - MoomooMoomoo · Fri, 07 Aug 2026 14:05:17 GMTViridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 19:02:19 GMTViridian Therapeutics 2Q 2026: Revenue $284K, EPS $(1.05) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:41:01 GMTFDA‑approved TED drug and new notes reshape Viridian Therapeutics (NASDAQ: VRDN) - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 11:32:22 GMT